SCHEMBL4172967

SCHEMBL4172967

CC(C)CNC(=O)c1c(F)c(F)c(F)c(F)c1F

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 4/20 0.82
TAS1R1 Q7RTX1 4/20 0.82
TAS1R2 Q8TE23 4/20 0.82
HTT P42858 1/20 0.55
SMN1; SMN2 Q16637 2/20 0.53
PKM P14618 1/20 0.53
HSD17B10 Q99714 2/20 0.52
GAA P10253 1/20 0.52
KMT2A Q03164 1/20 0.52
RECQL P46063 1/20 0.50
CYP2D6 P10635 1/20 0.46
CYP2C19 P33261 1/20 0.46
HPGD P15428 2/20 0.46
MLYCD O95822 1/20 0.46
TSHR P16473 1/20 0.46
MMP1 P03956 1/20 0.45
MMP8 P22894 1/20 0.45
ALDH1A1 P00352 1/20 0.42
ALOX12 P18054 1/20 0.42
KDM4E B2RXH2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL705624 0.90 TAS1R3 (1.00) TAS1R3TAS1R1TAS1R2HTTSMN1; SMN2
SCHEMBL24598454 0.84 TAS1R3 (0.61) TAS1R3TAS1R1TAS1R2HTTSMN1; SMN2
SCHEMBL20662856 0.83 TAS1R3 (0.79) TAS1R3TAS1R1TAS1R2HTTSMN1; SMN2
SCHEMBL18182635 0.76 HTT (0.61) TAS1R3TAS1R1TAS1R2HTTSMN1; SMN2
SCHEMBL24687425 0.75 HTT (0.67) TAS1R3TAS1R1TAS1R2HTTSMN1; SMN2
SCHEMBL15735617 0.75 TAS1R3 (0.50) TAS1R3TAS1R1TAS1R2HTTSMN1; SMN2
SCHEMBL21165338 0.74 TAS1R3 (0.73) TAS1R3TAS1R1TAS1R2HTTSMN1; SMN2
SCHEMBL5051925 0.73 RAB9A (0.49) TAS1R3TAS1R1TAS1R2HTTSMN1; SMN2
SCHEMBL15734359 0.73 TAS1R3 (0.49) TAS1R3TAS1R1TAS1R2HTTSMN1; SMN2
SCHEMBL15734193 0.73 TAS1R3 (0.49) TAS1R3TAS1R1TAS1R2HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090047379-A1 Benzamide Compounds Useful as High Potency Sweet Taste Enhancers DEWIS MARK L 2009-02-19 US disclosed
US-20090047379-A1 Benzamide Compounds Useful as High Potency Sweet Taste Enhancers DEWIS MARK L 2009-02-19 US disclosed
US-20090047379-A1 Benzamide Compounds Useful as High Potency Sweet Taste Enhancers DEWIS MARK L 2009-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090047379-A1 Benzamide Compounds Useful as High Potency Sweet Taste Enhancers TAS2R10, TAS2R50, TAS2R8 TAS1R3 27/4885TAS1R1 23/4885TAS1R2 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.